Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.58 $5.85 Friday, 10th May 2024 CTMX stock ended at $1.98. This is 2.94% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.81% from a day low at $1.85 to a day high of $2.05.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Mar 03, 2022 $4.12 $4.12 $3.78 $3.82 669 700
Mar 02, 2022 $3.89 $4.28 $3.78 $4.04 1 056 100
Mar 01, 2022 $3.82 $3.93 $3.53 $3.54 656 300
Feb 28, 2022 $4.02 $4.04 $3.83 $3.83 300 900
Feb 25, 2022 $3.96 $4.07 $3.93 $4.03 399 500
Feb 24, 2022 $3.93 $4.00 $3.76 $3.99 553 600
Feb 23, 2022 $4.16 $4.16 $4.00 $4.01 615 200
Feb 22, 2022 $4.06 $4.21 $4.02 $4.10 531 100
Feb 18, 2022 $4.05 $4.18 $4.02 $4.10 491 200
Feb 17, 2022 $4.09 $4.15 $4.05 $4.10 571 200
Feb 16, 2022 $4.09 $4.18 $3.97 $4.13 379 900
Feb 15, 2022 $4.14 $4.25 $3.96 $4.08 525 100
Feb 14, 2022 $4.39 $4.39 $4.05 $4.06 448 100
Feb 11, 2022 $4.45 $4.60 $4.33 $4.36 436 300
Feb 10, 2022 $4.58 $4.69 $4.39 $4.45 822 700
Feb 09, 2022 $4.55 $4.73 $4.48 $4.65 747 700
Feb 08, 2022 $4.35 $4.51 $4.33 $4.51 682 100
Feb 07, 2022 $4.30 $4.45 $4.27 $4.38 530 900
Feb 04, 2022 $4.14 $4.35 $4.13 $4.26 749 200
Feb 03, 2022 $4.08 $4.18 $4.05 $4.13 535 300
Feb 02, 2022 $4.65 $4.69 $4.13 $4.13 683 500
Feb 01, 2022 $4.62 $4.73 $4.40 $4.68 1 440 925
Jan 31, 2022 $4.37 $4.60 $4.37 $4.60 682 800
Jan 28, 2022 $4.18 $4.40 $4.15 $4.40 888 600
Jan 27, 2022 $4.39 $4.42 $4.18 $4.18 696 400
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT